Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against NovoCure Limited (NVCR)
LOS ANGELES, July 05, 2023 (GLOBE NEWSWIRE)
Overview
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming August 18, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired NovoCure Limited (“NovoCure” or the “Company”) (NASDAQ: NVCR) securities between January 5, 2023 and May 6, 2023, inclusive (the “Class Period”).
The lawsuit alleges that NovoCure made materially false and/or misleading statements and/or failed to disclose that: (1) demand for NovoCure’s Tumor Treating Fields (“TTFields”) therapy was declining; (2) as a result, NovoCure’s product sales were slowing; and (3) as a result of the foregoing, Defendants’ positive statements about NovoCure’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Impact on Investors
Investors who purchased NovoCure securities during the Class Period may be eligible to participate in the lawsuit to recover damages. It is important for investors to take action before the August 18, 2023 deadline to potentially be appointed as a lead plaintiff and recover their losses.
How This May Affect You
As an investor who purchased NovoCure securities during the Class Period, this lawsuit may have a direct impact on your financial standing. It is crucial to assess your options and consider participating in the lawsuit to potentially recover any losses incurred during this time.
Global Impact
The outcome of this class action lawsuit against NovoCure Limited may also have broader implications for the healthcare and biotechnology industry as a whole. It could serve as a precedent for how companies are held accountable for their statements and actions, affecting investor confidence and market stability worldwide.
Conclusion
In conclusion, the looming deadline in the class action lawsuit against NovoCure Limited is a critical reminder for investors to take action and protect their financial interests. It is recommended to consult with legal experts and consider participating in the lawsuit before the August 18, 2023 deadline to potentially recover any losses suffered during the Class Period.
